Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non‐industrial production of therapeutic lentiviral vectors: How to provide vectors to academic CAR‐T

4 Jul 2024

Abstract excerpt

Abstract Bringing effective cancer therapy in the form of chimeric antigen receptor technology to untapped markets faces numerous challenges, including a global shortage of therapeutic lentiviral or retroviral vectors on which all current clinical therapies using genetically modified T cells are based. Production of these lentiviral vectors in academic settings in principle opens the way to local production of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38963234
DOI: 10.1002/bit.28794

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non‐industrial production of therapeutic lentiviral vectors: How to provide vectors to academic CAR‐TPMID 38963234Read ↗

Optimized production and concentration of lentiviral vectors containing large insertsSemantic proximity Read ↗

Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cellsSemantic proximity Read ↗

Large-scale production of lentiviral vectors using multilayer cell factoriesSemantic proximity Read ↗

Lentiviral vector packaging and producer cell lines yield titers equivalent to the industry-standard four-plasmid processSemantic proximity Read ↗

Lentiviral Vectors for CAR-T and Other Cell Therapy Products: A Microbiological and Biosafety PerspectiveSemantic proximity Read ↗

Production of lentiviral vectorsSemantic proximity Read ↗

New developments in lentiviral vector design, production and purificationSemantic proximity Read ↗

Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free MediaSemantic proximity Read ↗

Manufacturing of recombinant adeno‐associated viruses using mammalian expression platformsSemantic proximity Read ↗

Lentivirus for CAR-T and Other Cell Therapy Products: A Microbiological and Biosafety PerspectiveSemantic proximity Read ↗

Viral vector manufacturing: how to address current and future demands?Semantic proximity Read ↗

Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing PracticeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.